Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Hamilton BK, Rybicki L, Dean R, Majhail NS, Haddad H, Abounader D, Hanna R, Sobecks R, Duong H, Hill BT, Copelan E, Bolwell B, Kalaycio M. Hamilton BK, et al. Among authors: duong h. Am J Hematol. 2015 Feb;90(2):144-8. doi: 10.1002/ajh.23882. Epub 2014 Nov 19. Am J Hematol. 2015. PMID: 25353395 Free article.
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.
Hamilton BK, Law AD, Rybicki L, Abounader D, Dabney J, Dean R, Duong HK, Gerds AT, Hanna R, Hill BT, Jagadeesh D, Kalaycio ME, Lawrence C, McLellan L, Pohlman B, Sobecks RM, Bolwell BJ, Majhail NS. Hamilton BK, et al. Among authors: duong hk. Bone Marrow Transplant. 2015 Sep;50(9):1235-40. doi: 10.1038/bmt.2015.122. Epub 2015 Jun 1. Bone Marrow Transplant. 2015. PMID: 26030045 Clinical Trial.
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Bejanyan N, Bolwell BJ, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks R, Dean R, Pohlman B, Kalaycio M, Copelan EA. Bejanyan N, et al. Among authors: duong h. Biol Blood Marrow Transplant. 2012 Jun;18(6):874-80. doi: 10.1016/j.bbmt.2011.10.032. Epub 2011 Oct 29. Biol Blood Marrow Transplant. 2012. PMID: 22040844 Free article.
Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
Lukenbill J, Rybicki L, Sekeres MA, Zaman MO, Copelan A, Haddad H, Fraser T, DiGiorgio MJ, Hanna R, Duong H, Hill B, Kalaycio M, Sobecks R, Bolwell B, Copelan E. Lukenbill J, et al. Among authors: duong h. Biol Blood Marrow Transplant. 2013 May;19(5):720-4. doi: 10.1016/j.bbmt.2013.01.022. Epub 2013 Feb 1. Biol Blood Marrow Transplant. 2013. PMID: 23380342 Free article.
Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M, Sun Y, Rybicki L, Zhang A, Thomas D, Kalaycio M, Pohlman B, Dean R, Duong H, Hanna R, Maciejewski J, Majhail NS, Bolwell B, Sobecks R. Askar M, et al. Among authors: duong h. Biol Blood Marrow Transplant. 2014 Nov;20(11):1835-40. doi: 10.1016/j.bbmt.2014.07.019. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064744 Free article.
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
Hamilton BK, Bolwell B, Kalaycio M, Rybicki L, Hanna R, Sobecks R, Pohlman B, Andresen S, Dean R, Duong H, Hill B, Copelan E. Hamilton BK, et al. Among authors: duong h. Bone Marrow Transplant. 2013 Nov;48(12):1578-80. doi: 10.1038/bmt.2013.89. Epub 2013 Jun 10. Bone Marrow Transplant. 2013. PMID: 23749105 Clinical Trial. No abstract available.
Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation.
Hamilton BK, Rybicki L, Dabney J, McLellan L, Haddad H, Foster L, Abounader D, Kalaycio M, Sobecks R, Dean R, Duong H, Hill BT, Bolwell BJ, Copelan EA. Hamilton BK, et al. Among authors: duong h. Bone Marrow Transplant. 2014 Nov;49(11):1426-31. doi: 10.1038/bmt.2014.166. Epub 2014 Jul 28. Bone Marrow Transplant. 2014. PMID: 25068430 Clinical Trial.
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.
Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, Duong H, Dean R, Hill B, Andresen S, Hanna R, Majhail N, Copelan E, Bolwell B, Kalaycio M, Sobecks R. Tavadze M, et al. Among authors: duong h. Bone Marrow Transplant. 2014 Oct;49(10):1310-6. doi: 10.1038/bmt.2014.150. Epub 2014 Aug 11. Bone Marrow Transplant. 2014. PMID: 25111516
665 results